Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity

Ilkow, 2014, From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer, PLoS Pathog., 10, e1003836, 10.1371/journal.ppat.1003836 Breitbach, 2016, Oncolytic viruses: therapeutics with an identity crisis, EBioMedicine, 9, 31, 10.1016/j.ebiom.2016.06.046 Swift, 2016, Big data offers novel insights for oncolytic virus immunotherapy, Viruses, 8, 45, 10.3390/v8020045 Lichty, 2014, Going viral with cancer immunotherapy, Nat. Rev. Cancer, 14, 559, 10.1038/nrc3770 Rehman, 2016, Into the clinic: talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy, J. Immunother. Cancer, 4, 53, 10.1186/s40425-016-0158-5 Russell, 2012, Oncolytic virotherapy, Nat. Biotechnol., 30, 658, 10.1038/nbt.2287 Altomonte, 2008, Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo, Mol. Ther., 16, 146, 10.1038/sj.mt.6300343 Arulanandam, 2015, Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing, Nat. Commun., 6, 6410, 10.1038/ncomms7410 Ben Yebdri, 2013, Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis, Mol. Ther., 21, 2043, 10.1038/mt.2013.187 Nguyên, 2008, Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis, Proc. Natl. Acad. Sci. USA, 105, 14981, 10.1073/pnas.0803988105 Ottolino-Perry, 2010, Intelligent design: combination therapy with oncolytic viruses, Mol. Ther., 18, 251, 10.1038/mt.2009.283 Shulak, 2014, Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy, J. Virol., 88, 2927, 10.1128/JVI.03406-13 Dobson, 2017, Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model, Oncotarget, 8, 3495, 10.18632/oncotarget.13849 Marchini, 2016, Overcoming barriers in oncolytic virotherapy with HDAC inhibitors and immune checkpoint blockade, Viruses, 8, 9, 10.3390/v8010009 Breitbach, 2010, Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval, Cytokine Growth Factor Rev., 21, 85, 10.1016/j.cytogfr.2010.02.001 Rowan, 2010, Oncolytic viruses move forward in clinical trials, J. Natl. Cancer Inst., 102, 590, 10.1093/jnci/djq165 Stojdl, 2000, Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus, Nat. Med., 6, 821, 10.1038/77558 Stojdl, 2003, VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents, Cancer Cell, 4, 263, 10.1016/S1535-6108(03)00241-1 Samuel, 2010, VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia, Mol. Ther., 18, 2094, 10.1038/mt.2010.188 Nguyen, 2009, The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress, J. Biol. Chem., 284, 13291, 10.1074/jbc.R900010200 Baird, 2013, Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex, Proc. Natl. Acad. Sci. USA, 110, 15259, 10.1073/pnas.1305687110 Jaramillo, 2013, The emerging role of the Nrf2-Keap1 signaling pathway in cancer, Genes Dev., 27, 2179, 10.1101/gad.225680.113 Greaney, 2016, Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism, J. Leukoc. Biol., 99, 189, 10.1189/jlb.3A0415-155RR Qi, 2016, Sulforaphane exerts anti-inflammatory effects against lipopolysaccharide-induced acute lung injury in mice through the Nrf2/ARE pathway, Int. J. Mol. Med., 37, 182, 10.3892/ijmm.2015.2396 Traka, 2008, Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate, PLoS ONE, 3, e2568, 10.1371/journal.pone.0002568 Alumkal, 2015, A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer, Invest. New Drugs, 33, 480, 10.1007/s10637-014-0189-z Cipolla, 2015, Effect of sulforaphane in men with biochemical recurrence after radical prostatectomy, Cancer Prev. Res. (Phila.), 8, 712, 10.1158/1940-6207.CAPR-14-0459 van Die, 2016, Phytotherapeutic interventions in the management of biochemically recurrent prostate cancer: a systematic review of randomised trials, BJU Int., 117, 17, 10.1111/bju.13361 Furfaro, 2016, The Nrf2/HO-1 axis in cancer cell growth and chemoresistance, Oxid. Med. Cell. Longev., 2016, 1958174, 10.1155/2016/1958174 Jeong, 2017, Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance, Cancer Discov., 7, 86, 10.1158/2159-8290.CD-16-0127 Singh, 2006, Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer, PLoS Med., 3, e420, 10.1371/journal.pmed.0030420 Lee, 2012, Reactive oxygen species and PI3K/Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1 expression in sulforaphane-treated human mesothelioma MSTO-211H cells, Food Chem. Toxicol., 50, 116, 10.1016/j.fct.2011.10.035 Lee, 2011, Sulforaphane induces antioxidative and antiproliferative responses by generating reactive oxygen species in human bronchial epithelial BEAS-2B cells, J. Korean Med. Sci., 26, 1474, 10.3346/jkms.2011.26.11.1474 Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc. Natl. Acad. Sci. USA, 99, 11908, 10.1073/pnas.172398899 Biswas, 2014, Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses, J. Biol. Chem., 289, 26882, 10.1074/jbc.M114.567685 Herman-Antosiewicz, 2006, Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells, Cancer Res., 66, 5828, 10.1158/0008-5472.CAN-06-0139 Jounai, 2007, The Atg5 Atg12 conjugate associates with innate antiviral immune responses, Proc. Natl. Acad. Sci. USA, 104, 14050, 10.1073/pnas.0704014104 Pajares, 2016, Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes, Autophagy, 12, 1902, 10.1080/15548627.2016.1208889 Hiscott, 2007, Triggering the innate antiviral response through IRF-3 activation, J. Biol. Chem., 282, 15325, 10.1074/jbc.R700002200 Zhang, 1992, A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure, Proc. Natl. Acad. Sci. USA, 89, 2399, 10.1073/pnas.89.6.2399 Fahey, 1997, Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens, Proc. Natl. Acad. Sci. USA, 94, 10367, 10.1073/pnas.94.19.10367 Lenzi, 2014, Sulforaphane as a promising molecule for fighting cancer, Cancer Treat. Res., 159, 207, 10.1007/978-3-642-38007-5_12 Dinkova-Kostova, 2017, KEAP1 and done? Targeting the NRF2 pathway with sulforaphane, Trends Food Sci. Technol., 10.1016/j.tifs.2017.02.002 Singh, 2005, Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species, J. Biol. Chem., 280, 19911, 10.1074/jbc.M412443200 Hu, 2011, Modification of keap1 cysteine residues by sulforaphane, Chem. Res. Toxicol., 24, 515, 10.1021/tx100389r Zhang, 2003, Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress, Mol. Cell. Biol., 23, 8137, 10.1128/MCB.23.22.8137-8151.2003 McMahon, 2010, Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals, Proc. Natl. Acad. Sci. USA, 107, 18838, 10.1073/pnas.1007387107 Alexander, 2010, ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS, Proc. Natl. Acad. Sci. USA, 107, 4153, 10.1073/pnas.0913860107 Otterbein, 2011, Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein, Proc. Natl. Acad. Sci. USA, 108, 14491, 10.1073/pnas.1102295108 Alain, 2010, Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production, Proc. Natl. Acad. Sci. USA, 107, 1576, 10.1073/pnas.0912344107 Yang, 2016, A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet, Sci. Rep., 6, 24399, 10.1038/srep24399 Liu, 2017, Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy, Nat. Commun., 8, 14754, 10.1038/ncomms14754 Simpson, 2016, Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances, Oncolytic Virother., 5, 1 Rajani, 2015, Harnessing the power of onco-immunotherapy with checkpoint inhibitors, Viruses, 7, 5889, 10.3390/v7112914 Bridle, 2013, Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccines, OncoImmunology, 2, e26013, 10.4161/onci.26013 Bridle, 2013, HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy, Mol. Ther., 21, 887, 10.1038/mt.2012.265 Lemay, 2017, Oncolytic viruses: the best is yet to come, Curr. Cancer Drug Targets Kallifatidis, 2011, Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate, Mol. Ther., 19, 188, 10.1038/mt.2010.216 Erzinger, 2016, Sulforaphane preconditioning sensitizes human colon cancer cells towards the bioreductive anticancer prodrug PR-104A, PLoS ONE, 11, e0150219, 10.1371/journal.pone.0150219 Higgins, 2011, The cap’n’collar transcription factor Nrf2 mediates both intrinsic resistance to environmental stressors and an adaptive response elicited by chemopreventive agents that determines susceptibility to electrophilic xenobiotics, Chem. Biol. Interact., 192, 37, 10.1016/j.cbi.2010.09.025 Wakabayashi, 2003, Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation, Nat. Genet., 35, 238, 10.1038/ng1248 Kovac, 2015, Nrf2 regulates ROS production by mitochondria and NADPH oxidase, Biochim. Biophys. Acta, 1850, 794, 10.1016/j.bbagen.2014.11.021 Kuma, 2004, The role of autophagy during the early neonatal starvation period, Nature, 432, 1032, 10.1038/nature03029 Olagnier, 2014, Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response, J. Virol., 88, 4180, 10.1128/JVI.03114-13 Chiang, 2015, Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists, J. Virol., 89, 8011, 10.1128/JVI.00845-15 Olagnier, 2014, Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells, PLoS Pathog., 10, e1004566, 10.1371/journal.ppat.1004566 Belgnaoui, 2012, Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex, Cell Host Microbe, 12, 211, 10.1016/j.chom.2012.06.009 Zhao, 2007, The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways, Nat. Immunol., 8, 592, 10.1038/ni1465 Ivanov, 2011, Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells, PLoS ONE, 6, e24957, 10.1371/journal.pone.0024957 Massrieh, 2006, Induction of endogenous Nrf2/small maf heterodimers by arsenic-mediated stress in placental choriocarcinoma cells, Antioxid. Redox Signal., 8, 53, 10.1089/ars.2006.8.53 Song, 2006, Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia, J. Cell. Physiol., 206, 655, 10.1002/jcp.20509